Imiquimod Clinical Trials

• Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
  ClinicalTrials.gov Identifier: NCT00116649 - Active, not recruiting
  Keratosis
  
• Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
  ClinicalTrials.gov Identifier: NCT00031759 - Active, not recruiting
  Cervical Cancer
  
• Study of Imiquimod 5% Cream as an Adjunct to Cryotherapy in the Management of Actinic Keratoses
  ClinicalTrials.gov Identifier: NCT00110682 - Active, not recruiting
  Keratosis; Actinic Keratosis
  
• Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer
  ClinicalTrials.gov Identifier: NCT00066872 - Active, not recruiting
  basal cell carcinoma of the skin
  
• Imiquimod in Children with Plaque Morphea
  ClinicalTrials.gov Identifier: NCT00147771 - Recruiting
  Morphea (localized scleroderma)
  
• Vaccine Therapy with Or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, Or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00118313 - Active, not recruiting
  stage II melanoma; stage III melanoma; Stage IV Melanoma
  
• Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis
  ClinicalTrials.gov Identifier: NCT00257530 - Not yet recruiting
  Cutaneous Leishmaniasis
  
• Imiquimod 5% Cream in Plaque-Type Morphea: A Pilot, Prospective Open-Label Study
  ClinicalTrials.gov Identifier: NCT00230373 - Active, not recruiting
  Morphea
  
• Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer
  ClinicalTrials.gov Identifier: NCT00079300 - Active, not recruiting
  Non-Melanomatous Skin Cancer
  
• Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands
  ClinicalTrials.gov Identifier: NCT00115154 - Completed
  Keratosis
  
• Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva
  ClinicalTrials.gov Identifier: NCT00504023 - Recruiting
  Vulvar Cancer
  
• A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00189241 - Active, not recruiting
  Basal Cell Carcinoma
  
• Vaccine Therapy With or Without Montanide ISA-51 and/or Imiquimod in Treating Patients With Melanoma That Has Been Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00304057 - Recruiting
  Melanoma (Skin)
  
• Open-Label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream
  ClinicalTrials.gov Identifier: NCT00189306 - Active, not recruiting
  Superficial Basal Cell Carcinoma
  
• Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts
  ClinicalTrials.gov Identifier: NCT00189293 - Recruiting
  Genital Warts
  
• Aldara™ (Trademark) (Imiquimod) Cream to Treat Basal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00045851 - Completed
  Basal Cell Carcinoma
  
• Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin
  ClinicalTrials.gov Identifier: NCT00453050 - Recruiting
  Melanoma (Skin); Metastatic Cancer
  
• Topical Imiquimod for Bowen's Disease of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00384124 - Not yet recruiting
  Bowens Disease
  
• A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence
  ClinicalTrials.gov Identifier: NCT00129519 - Completed
  Basal Cell Carcinoma
  
• NY-ESO-1 Protein Vaccine with Imiquimod in Melanoma (Adjuvant Setting)
  ClinicalTrials.gov Identifier: NCT00142454 - Completed
  Malignant Melanoma
  
• A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base
  ClinicalTrials.gov Identifier: NCT00463359 - Not yet recruiting
  Basal Cell Carcinoma
  
• 1-Year Follow up to the 1473-IMIQ Study
  ClinicalTrials.gov Identifier: NCT00114023 - Completed
  Keratosis
  
• A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00189267 - Completed
  Actinic Keratosis
  
• Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses
  ClinicalTrials.gov Identifier: NCT00175643 - Completed
  Actinic Keratoses
  
• Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
  ClinicalTrials.gov Identifier: NCT00335179 - Completed
  Actinic Keratosis
  
• Safety and Efficacy Study to Evaluate Imiquimod 5% Cream Applied 3x Per Week for 8 or 12 Weeks in Low Risk Nodular Basal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00204555 - Completed
  Carcinoma, Basal Cell
  
• Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage
  ClinicalTrials.gov Identifier: NCT00314756 - Completed
  Basal Cell Carcinoma